Follow the CERO THERAPEUTICS HOLDINGS, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €532k. The latest transaction was reported on 4 April 2025 (Levée d'options). Among the most active insiders: ATWOOD BRIAN G. The full history is free.
18
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€589,415
4 ops.
Sell Volume
22Σ signal
Buys n/a€589,415 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5,828 sharesClass A Common StockSEC:0001213900-24-015034:0
18 of 18 declarations
About CERO THERAPEUTICS HOLDINGS, INC.
CERO Therapeutics Holdings, Inc. is a company focused on developing innovative therapies to treat serious diseases. It is listed on NASDAQ under the ticker CERO.